Skip to main content
Clinical Trials/NL-OMON31517
NL-OMON31517
Recruiting
Phase 4

Wet-wrap treatment in children with atopic eczema using the wet-wrap method with diluted corticosteroids versus emollients - Wet Wrap study

Havenziekenhuis0 sites40 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
atopic dermatitis
Sponsor
Havenziekenhuis
Enrollment
40
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Havenziekenhuis

Eligibility Criteria

Inclusion Criteria

  • Age 6 months\- 6 years at inclusion
  • Diagnosis of atopic eczema with an objective SCORAD \>\= 40
  • Parent/legal guardian willing to comply with the protocol
  • Written, dated consent for subject to participate

Exclusion Criteria

  • Known pre\-existing, serious underlying disease
  • (secondary) infected eczema:
  • oIn case of overt impetiginisation, wet wrapping should be delayed until 48\-72 hours after commencing antibiotics and confirmation of appropriate treatment by skin swab results.
  • oEczema herpeticum is an absolute contraindication for the use of wet dressings.
  • Signs and symptoms of systemic infection (such as fever, defined as a temperature equivalent to a rectal temperature greater than 38\.3ºC).
  • Problems in the hypothalamus\-pituitary\-adrenal axis (HPA)
  • Systemic corticosteroid therapy
  • Severe growth retardation

Outcomes

Primary Outcomes

Not specified

Similar Trials